Thailand To Switch From Chinese To WHO Experts For Vaccine Plant
This article was originally published in PharmAsia News
Thailand's Government Pharmaceutical Organisation is canceling plans to rely on Chinese experts to build a plant in Thailand to produce avian influenza vaccines. The GPO's managing director said it would rely on the World Health Organization to provide the experts it needs. The Thai biotech agency previously had said it would work with the China National Biotech Group to build the plant. But the plan faced difficulties caused by a Japanese patent on the cell-based technology to be used and Chinese authorities were unable to reach a deal with the patent owners. (Click here for more
You may also be interested in...
Teva received a “package of commercial side-deals” for agreeing to halt generic competition to Cephalon’s Provigil (modafinil) throughout the EU, which it “would not have achieved without committing to staying out of the market,” according to findings by the European Commission.
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma